Arthritis Society – Ignite Innovation Grants – Abstract
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline: RIS review not required for abstract registration
External Deadline: Tuesday 25th, June 2024
Description
The goal of the Ignite Innovation Grant program is to support the development and testing of transformative, paradigm-shifting, concepts and approaches to address critical barriers to progress in arthritis research, challenge our understanding of arthritis and its management, and generate novel approaches to confront the challenges we face in defeating arthritis and delivering the best evidence-informed care possible. The program intends to foster novel, high-potential projects and ideas that could be expanded in the future through additional funding sources (i.e., successful operating grants, industry partnership programs, cross discipline funding opportunities, etc.).
Successfully funded Ignite Innovation projects are based on “high risk” ideas that have a strong potential for “high reward”. The scope of high-risk projects could include proposals that focus on novel or untested tool development, cellular pathways, behavioural or psychosocial methodologies, research to address or ameliorate social or structural inequities, novel methods for delivering evidenced-based treatment or self-care interventions, unconventional devices, or techniques/procedures (including measures) and/or have potential for unique translation. As projects are at an early stage of development, a high level of risk is expected and not all projects will yield anticipated results. High reward is defined as the potential to create a significant and real change or impact. Applicants must explain the anticipated change or impact that is likely to result and to whom or what will be affected by the change, and its significance. To support the novelty of the project, a thorough evaluation of the literature should be included. Applicants will be required to describe why the project is novel, as it relates to the latest methods, concepts, information, and techniques.
This program encourages bold attempts to test novel hypotheses and/or generate new knowledge and/or improvements related to prevention, detection, diagnosis, treatment, and support; therefore, while projects must be feasible and doable by the applicant(s), preliminary data is not necessary.
Applications are encouraged from all areas and disciplines of arthritis research, as well as from investigators in other disciplines whose ideas are relevant to the field of arthritis research. Diverse partnerships that advance and accelerate the application of the research are encouraged. These may include transdisciplinary research approaches and/or partnerships with industry, policy makers, consumers, health care providers and others. Note that the next logical step or incremental advancement on published data is not considered innovative and should not be submitted to this competition.
Arthritis Society Canada and the Canadian Dupuytren Society are announcing a new research funding opportunity under the 2024 Ignite Innovation Grant program. Like arthritis, Dupuytren Disease is a common and debilitating condition that can occur in people of any age and sex and for which there is currently no cure. Dupuytren Disease is a heritable condition that affects connective tissues (fascia, skin, and nerves) of the hands, can result in palm and finger contractures and, similar to arthritis, causes debilitating and permanent loss of hand function. Individuals living with Dupuytren Disease report increased anxiety, mood and mental health disorders, and devastating challenges in maintaining their chosen professions, just like those with arthritis. Studies that could impact people that experience the symptoms of Dupuytren’s Disease are eligible to apply for top up funding (max $10,000). More details on this funding can be found here.
See the Arthritis Society website for more information.
Abstract Registration submission deadline: May 14, 2024 5:00 PM ET
Full application available: May 16, 2024
Full application submission deadline: June 25, 2024, 5:00 PM ET